Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice - PubMed (original) (raw)
Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice
D E Clouthier et al. J Clin Invest. 1997.
Abstract
Transgenic mice overexpressing a constitutively active human TGF-beta1 under control of the rat phosphoenolpyruvate carboxykinase regulatory sequences developed fibrosis of the liver, kidney, and adipose tissue, and exhibited a severe reduction in body fat. Expression of the transgene in hepatocytes resulted in increased collagen deposition, altered lobular organization, increased hepatocyte turnover, and in extreme cases, hemorrhage and thrombosis. Renal expression of the transgene was localized to the proximal tubule epithelium, and was associated with tubulointerstitial fibrosis, characterized by excessive collagen deposition and increased fibronectin and plasminogen activator inhibitor-1 immunoreactivity. Pronounced glomerulosclerosis was evident, and hydronephrosis developed with low penetrance. Expression of TGF-beta1 in white and brown adipose tissue resulted in a lipodystrophy-like syndrome. All white fat depots and brown fat pads were severely reduced in size, and exhibited prominent fibroplasia. This reduction in WAT was due to impaired adipose accretion. Introduction of the transgene into the ob/ob background suppressed the obesity characteristic of this mutation; however, transgenic mutant mice developed severe hepato- and splenomegaly. These studies strengthen the link between TGF-beta1 expression and fibrotic disease, and demonstrate the potency of TGF-beta1 in modulating mesenchymal cell differentiation in vivo.
Similar articles
- Glomerulosclerosis, tubulointerstitial fibrosis, and obstructive uropathy in PEPCK-TGF-beta1 transgenic mice.
Kopp JB. Kopp JB. Am J Kidney Dis. 1999 Jul;34(1):177-83. doi: 10.1016/s0272-6386(99)70128-9. Am J Kidney Dis. 1999. PMID: 10401036 No abstract available. - TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis.
Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, Rose-John S, zum Büschenfelde KH, Blessing M. Kanzler S, et al. Am J Physiol. 1999 Apr;276(4):G1059-68. doi: 10.1152/ajpgi.1999.276.4.G1059. Am J Physiol. 1999. PMID: 10198351 - Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.
Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Sanderson N, et al. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2572-6. doi: 10.1073/pnas.92.7.2572. Proc Natl Acad Sci U S A. 1995. PMID: 7708687 Free PMC article. - Cell-specific expression of cytosolic phosphoenolpyruvate carboxykinase in transgenic mice.
Beale EG, Clouthier DE, Hammer RE. Beale EG, et al. FASEB J. 1992 Dec;6(15):3330-7. doi: 10.1096/fasebj.6.15.1281456. FASEB J. 1992. PMID: 1281456 Review. - Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments].
Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, Stahl RA. Wolf G, et al. Kidney Int. 1999 Sep;56(3):860-72. doi: 10.1046/j.1523-1755.1999.00626.x. Kidney Int. 1999. PMID: 10469355
Cited by
- Multiple cytokine analysis of aqueous humor in uveitis with or without secondary glaucoma.
Xiao J, Zhao C, Cheng G, Song H, Zhang Y, Zhang M. Xiao J, et al. BMC Ophthalmol. 2024 Oct 15;24(1):451. doi: 10.1186/s12886-024-03691-4. BMC Ophthalmol. 2024. PMID: 39407182 Free PMC article. - MicroRNAs as Epigenetic Regulators of Obesity.
Engin AB, Engin A. Engin AB, et al. Adv Exp Med Biol. 2024;1460:595-627. doi: 10.1007/978-3-031-63657-8_20. Adv Exp Med Biol. 2024. PMID: 39287866 Review. - Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases.
Morguetti MJ, Neves PDMM, Korkes I, Padilha WSC, Jorge LB, Watanabe A, Watanabe EH, Malheiros DMAC, Noronha IL, Dib SA, Onuchic LF, Moisés RS. Morguetti MJ, et al. Arch Endocrinol Metab. 2024 May 10;68:e230204. doi: 10.20945/2359-4292-2023-0204. Arch Endocrinol Metab. 2024. PMID: 38739524 Free PMC article. - The blockade of the TGF-β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesity.
Xu WD, Lai SZ, Zhao J, Wei SJ, Fang XY, Liu YY, Rong XL, Guo J. Xu WD, et al. Pharmacol Res Perspect. 2024 Feb;12(1):e1160. doi: 10.1002/prp2.1160. Pharmacol Res Perspect. 2024. PMID: 38174807 Free PMC article. - Biomimetic Systems Involving Macrophages and Their Potential for Targeted Drug Delivery.
Savchenko IV, Zlotnikov ID, Kudryashova EV. Savchenko IV, et al. Biomimetics (Basel). 2023 Nov 12;8(7):543. doi: 10.3390/biomimetics8070543. Biomimetics (Basel). 2023. PMID: 37999184 Free PMC article. Review.
References
- Am J Physiol. 1993 Oct;265(4 Pt 2):F537-41 - PubMed
- J Cell Biol. 1989 Mar;108(3):1105-13 - PubMed
- J Cell Biochem. 1994 Feb;54(2):256-63 - PubMed
- J Clin Invest. 1994 Jun;93(6):2431-7 - PubMed
- Exp Nephrol. 1994 Jan-Feb;2(1):13-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous